Compounds targeting the C-terminal allosteric pocket inhibit HSP70, inducing mitochondrial cell death in cancer cells while sparing normal tissue.
A phosphoric acid catalyst enables synthesis of N-phosphonomethyliminodiacetic acid using P-O-P anhydride moieties.
Targeted compounds inhibit leukemic stem cells via HCK and BCL-2 pathways to prevent acute myeloid leukemia recurrence.
A phosphinimine amido-ether complex coordinates group 4 metals to form single-site olefin polymerization catalysts.
A lipid derivative uses a cyclic benzylidene acetal linker to attach hydrophilic polymers via acid-labile bonds.
Modified protease inhibitors maintain efficacy against mutant HIV strains by altering aromatic ring substituents and linker groups to preserve binding affinity.
Segmented synthesis of paricalcitol via ozonolysis improves efficiency while maintaining therapeutic efficacy.
Specific fluorene derivatives replace expensive iridium complexes, resolving the trade-off between device performance and manufacturing cost.
Oxidized platinum on carbon minimizes leaching and formaldehyde by-products during PMIDA conversion.
Small-molecule PSMA inhibitors replace large antibodies to overcome immunogenicity and poor vascular permeability in prostate cancer imaging.
Substituted imidazolium compounds with multiple acidic groups treat bone, cancer, and inflammatory pain conditions.
A novel compound with a 7-membered ring segment transports electrons and blocks holes in organic electronic devices.
DOPO-based compounds improve thermal stability and hydrolysis resistance in epoxy resins.
Base-metal complexes replace platinum to lower cost while resisting carbon monoxide poisoning.
A phosphonic acid adhesion promoter reacts with hydroxyalkyl methacrylate to form a polymerizable bonding agent.
A heterocyclic compound acts as a multifunctional layer in organic light emitting devices to lower driving voltage.
Dipole re-orientation in a molecular layer switches resistance states, reducing free-radical degradation and improving memory endurance.
Lithium bis(oxalato)borate electrolyte prevents thermal runaway and gas formation in high-energy-density batteries.
A fluorinated cyclic carbonate compound replaces phosphoric acid retardants in lithium battery electrolytes to lower viscosity and improve initial irreversible efficiency.
Triphenylphosphonium-linked honokiol inhibits mitochondrial complex I to overcome drug resistance and reduce toxicity.
LLP2A-bisphosphonate conjugates direct mesenchymal stem cells to bone surfaces, restoring bone formation without damaging endogenous cells.
A flame-retardant polyurethane composition combines a thermoplastic resin with phosphorus particulate fillers and low-melting agents.
A spiro-type compound enhances organic light emitting device performance through multi-layer functionality.
Conjugating ketamine to carrier molecules protects the drug from pre-systemic metabolism, improving oral bioavailability while reducing abuse potential.
Specific substituents on the organic compound stabilize the absorption spectrum against temperature fluctuations, ensuring consistent color performance.
Redox assay compounds detect cellular NAD(P)H levels through direct bioluminescence signals.
Phosphinated poly(2,6-dimethyl phenylene oxide) oligomers cure into thermosets meeting UL-94 V-0 flammability standards.
Segmented amiloride derivatives expand therapeutic options for chronic bronchitis and asthma by blocking epithelial sodium channels.
Dual-acid tenofovir alafenamide co-crystals resolve low permeability by enhancing dissolution rates and stability for improved bioavailability.
Formula I agents block viral entry to reduce disease progression and resistance.
Heteroaryl compounds inhibit SUMO activating enzyme to treat proliferative, inflammatory, cardiovascular, and neurodegenerative disorders.
Lewis acid catalyzed Prins reactions form the C.23-C.24 bond, resolving stereoselectivity and synthesis efficiency trade-offs.
Controlled crystallization eliminates sticky solvates from bisphosphite ligands, delivering free-flowing powders suitable for transition metal catalysts.
D-(π)-σ-(π)-A host compound interrupts intramolecular charge transfer to reduce excited-state dipole moment, mitigating triplet state-triplet state quenching.
Stabilized gold(III) bis(pyrrolide-imine) complexes overcome physiological instability and cisplatin resistance by intercalating DNA.
A phosphine-based compound with a phenylene linker and nitrogen-containing aromatic ring serves as an organic electroluminescence host material.
Phosphorous-containing polymer enhances polyamide flame retardancy without clogging spinning nozzles.
Humic substance-based binder system eliminates organic solvents and formaldehyde while maintaining mold strength.
A micro-reaction system prepares alkyl phosphate compounds through sequential condensation in micro-channel reactors.
Siloxane bonding stabilizes the vesicle structure during electroless plating, enabling functional nano-material creation.
Amphiphilic compounds incorporate chemoselective functional groups into liposomes to enable controlled cellular adhesion and fusion.
A photoinduced emulsion polymerization process synthesizes polymer nanoparticles using specific photoinitiators to generate radicals under electromagnetic radiation.
Selective compounds inhibit DNA repair in damaged cells, sparing healthy tissue from chemotherapy side effects.
Glycol ethers prevent NBPT crystallization at low temperatures, resolving the contradiction between high concentration and solidification.
React rare earth compounds with organophosphorus acids in minimal solvent to produce high purity solutions.
A condensed cyclic compound with a phenazine core structure enhances electron transport within organic light-emitting devices.
A heterocyclic compound optimizes hole and electron recombination in organic light-emitting device emission layers.